Invesco
VRCA icon

Invesco’s Verrica Pharmaceuticals VRCA Stock Holding History

Invesco’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,439
Closed -$32.9K – 3885
2025
Q1 		$32.9K Buy
7,439
+2,926
+65% +$18.9K ﹤0.01% 3724
2024
Q4 		$31.6K Buy
+4,513
New +$49.6K ﹤0.01% 3723
2024
Q3 		– Sell
-42,352
Closed -$3.09M – 3897
2024
Q2 		$3.09M Buy
+42,352
New +$3.25M ﹤0.01% 2407
2023
Q4 		– Sell
-1,066
Closed -$41.4K – 3899
2023
Q3 		$41.4K Hold
1,066
– – ﹤0.01% 3814
2023
Q2 		$61.5K Buy
+1,066
New +$64.7K ﹤0.01% 3799

Other funds holding VRCA

CP
Caligan Partners New York $1.41B AUM 518.95% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SA
Sovran Advisors San Diego, California $1.27B AUM 18.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return